Regulatory News:
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated
to helping people see brilliantly, today announced changes to its
Executive Committee of Alcon (ECA). Changes take effect September
1, 2021.
- Ian Bell, currently President, International, and a member of
the ECA, is named President, Global Business & Innovation.
Michael Onuscheck, current President, Global Business &
Innovation, and a member of the ECA, will be stepping down from his
roles at the Company.
- Raj Narayanan, Senior Vice President, Operational Strategy and
Chief Transformation Officer, and a member of the ECA, will succeed
Ian Bell as President, International.
- Sue-Jean Lin, Senior Vice President & Chief Information
Officer, will be appointed as Senior Vice President, Chief
Information & Transformation Officer and will add oversight of
Alcon’s Transformation program to her remit. She will also become a
member of the ECA.
“We are excited to have Ian’s leadership advancing our
innovation agenda, where he can bring his deep industry experience
and International successes to drive our portfolio decision
making,” said David Endicott, Chief Executive Officer at Alcon.
“Ian’s passion for seeking customer insights that inform our
product development will continue to be a core characteristic of
Alcon’s strength.”
“On behalf of everyone at Alcon, I want to thank Michael for his
leadership in building our Global Business and Innovation team,
which has advanced one of the strongest pipelines in eye care,”
said Mr. Endicott. “It has been a privilege to work with the Alcon
team over the past six years to build an industry leader,” said Mr.
Onuscheck. “I am proud of the work we have done to create value for
our customers and improve patients’ lives.”
“We are also pleased that Raj has agreed to lead our
International business. His significant commercial experience in
both Europe and Asia, and his success establishing our
Transformation program, make him the natural successor to Ian,”
said Mr. Endicott. “We are equally thrilled to welcome Sue-Jean to
the Executive Committee. She has made tremendous contributions to
date, including successfully separating Alcon’s systems and
processes in our stand up as an independent public company. Her
deep understanding of our ways of working will continue to advance
our transformation agenda.”
“We are emerging from COVID-19 as an even stronger company and
are inspired by the significant opportunities we have to advance
the frontiers of sight. These changes will allow us to further
accelerate our growth while continuing to advance our purpose of
helping people see brilliantly.”
The ECA will remain with seven committee members and effective
September 1, will be comprised of the following members: David
Endicott, Laurent Attias, Ian Bell, Sergio Duplan, Sue-Jean Lin,
Raj Narayanan, and Tim Stonesifer.
About the ECA
The ECA, led by Chief Executive David Endicott, is a governing
body responsible for the overall management of Alcon. The ECA
prepares and, upon approval of the Board, implements corporate
policies, strategies and strategic plans. The ECA also coordinates
Alcon’s various functions to achieve its business targets and
ensures the efficient operation of the Alcon business, managing its
use of capital and financial resources. The ECA prepares and
submits quarterly and annual financial reports for the attention
and approval of the Board or its Committees and keeps the Board
informed of all matters of fundamental significance to the
business.
Executive Bios
Ian Bell is currently President, International,
overseeing Europe, Middle East and Africa, Asia Pacific, China,
Japan and Latin America and is a member of the ECA. He joined Alcon
in March 2016 as President of EMEA. He brings extensive
international, sales, marketing and strategy experience having
served most recently in a senior role at Hospira Inc.
Raj Narayanan is currently Senior Vice President,
Operational Strategy and Chief Transformation Officer, and a member
of the ECA. He joined Alcon in June 2017 as President, Asia Pacific
Region from Allergan, Inc., where he worked for 22 years in roles
of increasing responsibility, in multiple international
markets.
Sue-Jean Lin is currently Senior Vice President &
Chief Information Officer for Alcon and a member of the Executive
Leadership Team. She joined Alcon in August of 2018. Sue-Jean
brings extensive IT and Digital leadership experience having served
most recently in senior roles at Hill-Rom, a global medical
technology company.
Additional Information
Information regarding the Executive Committee of Alcon and the
members of the Committee can be found online at Alcon’s Investor
Relations website, or by clicking on the link:
https://investor.alcon.com/governance/executive-committee/default.aspx
Forward-looking
Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. Should one or more of these
uncertainties or risks materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated. Therefore, you should not rely on any of
these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date they are made, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
ABOUT ALCON
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 23,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210628005620/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Wes Warnock
+ 41 589 112 111 (Geneva) + 1 817 615 2501 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024